Literature DB >> 20147902

Breast and prostate cancer: more similar than different.

Gail P Risbridger1, Ian D Davis, Stephen N Birrell, Wayne D Tilley.   

Abstract

Breast cancer and prostate cancer are the two most common invasive cancers in women and men, respectively. Although these cancers arise in organs that are different in terms of anatomy and physiological function both organs require gonadal steroids for their development, and tumours that arise from them are typically hormone-dependent and have remarkable underlying biological similarities. Many of the recent advances in understanding the pathophysiology of breast and prostate cancers have paved the way for new treatment strategies. In this Opinion article we discuss some key issues common to breast and prostate cancer and how new insights into these cancers could improve patient outcomes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20147902     DOI: 10.1038/nrc2795

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  126 in total

Review 1.  Cancer immunoediting: from immunosurveillance to tumor escape.

Authors:  Gavin P Dunn; Allen T Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

2.  Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer.

Authors:  Mark A Titus; Michael J Schell; Fred B Lih; Kenneth B Tomer; James L Mohler
Journal:  Clin Cancer Res       Date:  2005-07-01       Impact factor: 12.531

3.  Steroid hormone receptor expression in male breast cancer.

Authors:  C E Murphy; P J Carder; M R J Lansdown; V Speirs
Journal:  Eur J Surg Oncol       Date:  2005-11-02       Impact factor: 4.424

Review 4.  History of aromatase: saga of an important biological mediator and therapeutic target.

Authors:  R J Santen; H Brodie; E R Simpson; P K Siiteri; A Brodie
Journal:  Endocr Rev       Date:  2009-04-23       Impact factor: 19.871

5.  Adjuvant hormonal therapy for breast cancer and risk of hormone receptor-specific subtypes of contralateral breast cancer.

Authors:  Christopher I Li; Janet R Daling; Peggy L Porter; Mei-Tzu C Tang; Kathleen E Malone
Journal:  Cancer Res       Date:  2009-08-25       Impact factor: 12.701

6.  Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer.

Authors:  Amelia A Peters; Grant Buchanan; Carmela Ricciardelli; Tina Bianco-Miotto; Margaret M Centenera; Jonathan M Harris; Shalini Jindal; Davendra Segara; Li Jia; Nicole L Moore; Susan M Henshall; Stephen N Birrell; Gerhard A Coetzee; Robert L Sutherland; Lisa M Butler; Wayne D Tilley
Journal:  Cancer Res       Date:  2009-07-28       Impact factor: 12.701

7.  BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription.

Authors:  Sook Shin; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-19       Impact factor: 11.205

Review 8.  Mesenchymal-epithelial interactions: past, present, and future.

Authors:  Gerald R Cunha
Journal:  Differentiation       Date:  2008-06-28       Impact factor: 3.880

9.  Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial.

Authors:  T J Murtola; T L J Tammela; L Määttänen; M Ala-Opas; U H Stenman; A Auvinen
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640

10.  Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer.

Authors:  Gerhardt Attard; Alison H M Reid; Roger A'Hern; Christopher Parker; Nikhil Babu Oommen; Elizabeth Folkerd; Christina Messiou; L Rhoda Molife; Gal Maier; Emilda Thompson; David Olmos; Rajesh Sinha; Gloria Lee; Mitch Dowsett; Stan B Kaye; David Dearnaley; Thian Kheoh; Arturo Molina; Johann S de Bono
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

View more
  85 in total

1.  Teasing out the role of aromatase in the healthy and diseased testis.

Authors:  Jenna T Haverfield; Seungmin Ham; Kristy A Brown; Evan R Simpson; Sarah J Meachem
Journal:  Spermatogenesis       Date:  2011-07-01

2.  New secrets behind bone metastasis.

Authors:  Xing Guo; Xiao-Fan Wang
Journal:  Cell Res       Date:  2012-06-26       Impact factor: 25.617

3.  Breast and prostate cancer: familial associations.

Authors:  Kari Hemminki; Asta Försti; Bowang Chen
Journal:  Nat Rev Cancer       Date:  2010-07       Impact factor: 60.716

Review 4.  Estrogen receptors and human disease: an update.

Authors:  Katherine A Burns; Kenneth S Korach
Journal:  Arch Toxicol       Date:  2012-05-31       Impact factor: 5.153

5.  Androgen resistance in female mice increases susceptibility to DMBA-induced mammary tumors.

Authors:  Ulla Simanainen; Yan Ru Gao; Kirsty A Walters; Geoff Watson; Reena Desai; Mark Jimenez; David J Handelsman
Journal:  Horm Cancer       Date:  2012-06       Impact factor: 3.869

6.  Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions.

Authors:  David C Qian; Jinyoung Byun; Younghun Han; Casey S Greene; John K Field; Rayjean J Hung; Yonathan Brhane; John R Mclaughlin; Gordon Fehringer; Maria Teresa Landi; Albert Rosenberger; Heike Bickeböller; Jyoti Malhotra; Angela Risch; Joachim Heinrich; David J Hunter; Brian E Henderson; Christopher A Haiman; Fredrick R Schumacher; Rosalind A Eeles; Douglas F Easton; Daniela Seminara; Christopher I Amos
Journal:  Hum Mol Genet       Date:  2015-10-19       Impact factor: 6.150

7.  Cancers of the breast and prostate: a stem cell perspective.

Authors:  Dean G Tang
Journal:  Endocr Relat Cancer       Date:  2015-12       Impact factor: 5.678

8.  FASLG T844C polymorphism and susceptibility to breast cancer: a meta-analysis.

Authors:  Ou Huang; Min Jiang; Xi Zhang; Xiaosong Chen; Jiayi Wu; Kunwei Shen
Journal:  Tumour Biol       Date:  2014-01-11

9.  Quantitative synthesis of the association between the cytochrome P450 1A1 Ile462Val polymorphism and prostate cancer risk.

Authors:  Guangye Han; Yanjuan Ma; Pei Liu; Xiaoxia Wei; Xinjun Zhang; Feng Zhu
Journal:  Tumour Biol       Date:  2013-02-06

Review 10.  Association between the GSTP1 Ile105Val polymorphism and prostate cancer risk: a systematic review and meta-analysis.

Authors:  Zhuo Yu; Zhong Li; Bing Cai; Ziming Wang; Weimin Gan; Haiwen Chen; Hecheng Li; Peng Zhang; Hongliang Li
Journal:  Tumour Biol       Date:  2013-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.